Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

OptiCept Technologies

3,78

 

SEK

 

+0,8 %

Mindre end 1K følgere

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Sammenligne
+0,8%
+0,53%
-8,92%
-14,38%
-23,79%
-31,05%
-90,23%
-86,39%
-25,04%

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Læs mere
Markedsværdi
246,25 mio. SEK
Aktieomsætning
612,14 t SEK
Omsætning
17,67 mio.
EBIT %
-317,43 %
P/E
-
Udbytteafkast, %
-
Seneste analyse

Seneste analyse

Released: 02.12.2024

Seneste omfattende analyse

Released: 02.02.2024

Finanskalender
28.8
2025

Delårsrapport Q2'25

27.11
2025

Delårsrapport Q3'25

Alle
Analyse
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Pressemeddelelse8.7.2025, 13.11

DNB Carnegie Access: OptiCept Technologies: Spain order supports order intake momentum

OptiCept Technologies
Pressemeddelelse8.7.2025, 11.00

New Order from Spain – OptiCept Continues to Gain Ground in the Olive Oil Industry

OptiCept Technologies
Pressemeddelelse19.6.2025, 06.55

OptiCept: Strong end to the week – new orders totaling SEK 10 million

OptiCept Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse18.6.2025, 19.44

OptiCept receives order for CEPT® system for olive oil extraction from leading Portuguese producer

OptiCept Technologies
Selskabsmeddelelse18.6.2025, 15.47

New order from Spain: OptiCept's CEPT® technology chosen for olive oil extraction

OptiCept Technologies
Pressemeddelelse16.6.2025, 09.07

DNB Carnegie Access: OptiCept Technologies: CEPT order from the juice industry

OptiCept Technologies
Selskabsmeddelelse16.6.2025, 06.59

OptiCept Receives Order from Dole Worth 4 MSEK

OptiCept Technologies
Pressemeddelelse11.6.2025, 13.00

OptiCept Launches Validation Project with Leading Juice Producer in Vietnam

OptiCept Technologies
Pressemeddelelse9.6.2025, 06.30

OptiCept Receives Order for CEPT® System for Olive Oil Extraction from Spanish Producer

OptiCept Technologies
Pressemeddelelse30.5.2025, 05.15

DNB Carnegie Access: OptiCept Technologies: Secures financing, FPS timing questions remain – Q1 review

OptiCept Technologies
Selskabsmeddelelse29.5.2025, 06.00

OptiCept Technologies Interim Report Q1 2025

OptiCept Technologies
Pressemeddelelse21.5.2025, 10.30

OptiCept Initiates Collaboration with Tropical Food Machinery

OptiCept Technologies
Pressemeddelelse14.5.2025, 06.30

OptiCept Exhibits at Expoliva

OptiCept Technologies
Pressemeddelelse13.5.2025, 07.39

DNB Carnegie Access: OptiCept Technologies: Rights issue and loan to support current burn rate

OptiCept Technologies
Pressemeddelelse8.5.2025, 15.09

Carnegie Access: OptiCept Technologies: Anticipating backend-loaded revenue in 2025

OptiCept Technologies
Pressemeddelelse29.4.2025, 10.50

OptiCept granted a new patent for the treatment of liquid food products

OptiCept Technologies
Selskabsmeddelelse2.4.2025, 09.56

OptiCept receives key order from existing customer in Spain

OptiCept Technologies
Pressemeddelelse1.4.2025, 06.30

OptiCept strengthens collaboration with Acesur

OptiCept Technologies
Pressemeddelelse31.3.2025, 07.07

Carnegie Access: OptiCept Technologies: FPS revenue pushed back, progress in cuttings – Q4 review

OptiCept Technologies
Selskabsmeddelelse28.3.2025, 07.00

OptiCept Technologies Year-End Report Q4 2024

OptiCept Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.